Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Arcadia Biosciences, Inc. - Common Stock (NQ: RKDA )

6.350 +0.130 (+2.09%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 56,193
Open 6.100
Bid (Size) 6.220 (1)
Ask (Size) 6.350 (20)
Prev. Close 6.220
Today's Range 5.730 - 6.350
52wk Range 1.851 - 10.31
Shares Outstanding 950,406
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFIE, CDMO, RKDA on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
ARCADIA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Arcadia Biosciences, Inc. - RKDA
From Kahn Swick & Foti, LLC
Via Business Wire

Performance

YTD
+118.21%
+118.21%
1 Month
+144.89%
+144.89%
3 Month
+114.17%
+114.17%
6 Month
+95.38%
+95.38%
1 Year
+115.25%
+115.25%

More News

Read More
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CCRN, RKDA, ENLC on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Earnings Scheduled For November 12, 2024
Via Benzinga
Recap: Arcadia Biosciences Q4 Earnings
Via Benzinga
Shareholder Alert: Ademi LLP investigates whether Arcadia Biosciences, Inc. is obtaining a Fair Price for its Public Shareholders
From Ademi LLP
Via Business Wire
Crude Oil Edges Lower; US Initial Jobless Claims Increase
Via Benzinga
Exposures Fossil Fuels
Arcadia Biosciences Stock Are On The Rise Today: What's Going On?
Via Benzinga
RKDA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Arcadia Biosciences, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Dow Falls 50 Points; Kroger Posts Downbeat Sales
Via Benzinga
Topics Stocks
Exposures US Equities
Arcadia Biosciences (RKDA) Enters Into Business Combination Agreement with Roosevelt Resources in All-Stock Transaction
From Arcadia Biosciences, Inc.
Via Business Wire
Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2024 Financial Results and Business Highlights
From Arcadia Biosciences, Inc.
Via Business Wire
Arcadia Biosciences (RKDA) Announces Date of Third Quarter 2024 Financial Results and Business Highlights Conference Call
From Arcadia Biosciences, Inc.
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
RKDA Stock Earnings: Arcadia Biosciences Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Arcadia Biosciences (RKDA) Announces Second-Quarter and First-Half 2024 Financial Results and Business Highlights
From Arcadia Biosciences, Inc.
Via Business Wire
Arcadia Biosciences (RKDA) Announces Date of Second Quarter 2024 Financial Results and Business Highlights Conference Call
From Arcadia Biosciences, Inc.
Via Business Wire
Arcadia Biosciences (RKDA) Announces Leadership Transition
From Arcadia Biosciences, Inc.
Via Business Wire
Arcadia Biosciences (RKDA) To Host Investor Call To Discuss Recent Transactions
From Arcadia Biosciences, Inc.
Via Business Wire
Arcadia Biosciences (RKDA) Announces Sale of GoodWheatTM to Above Food Corp.
From Arcadia Biosciences, Inc.
Via Business Wire
Arcadia Biosciences (RKDA) Announces Sale of Resistant Starch Durum Wheat Trait to Corteva Agriscience (CTVA)
From Arcadia Biosciences, Inc.
Via Business Wire
RKDA Stock Earnings: Arcadia Biosciences Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Arcadia Biosciences (RKDA) Announces First Quarter 2024 Financial Results and Business Highlights
From Arcadia Biosciences, Inc.
Via Business Wire
Arcadia Biosciences (RKDA) Announces Date of First Quarter 2024 Financial Results and Business Highlights Conference Call
From Arcadia Biosciences, Inc.
Via Business Wire
RKDA Stock Earnings: Arcadia Biosciences Beats EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.